Serum amyloid P (SAP) is associated with impaired brachial artery flow-mediated dilation in chronically HIV-1 infected adults on stable antiretroviral therapy

References

• Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KLet al., HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173(8):614–622.
   PubMed Web of Science ®Google Scholar
• Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92(7):2506–2512.
   PubMed Web of Science ®Google Scholar
• Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115(10):1285–1295.
   PubMed Web of Science ®Google Scholar
• Gutierrez E, Flammer AJ, Lerman LO, Elizaga J, Lerman A, Fernandez-Aviles F. Endothelial dysfunction over the course of coronary artery disease. Eur Heart J. 2013;34(41):3175–3181.
   PubMed Web of Science ®Google Scholar
• Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation. 2007;115(18):2390–2397.
   PubMed Web of Science ®Google Scholar
• Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post Wet al., Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation. 2009;120(6):502–509.
   PubMed Web of Science ®Google Scholar
• Rossi R, Nuzzo A, Origliani G, Modena MG. Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. J Am Coll Cardiol. 2008;51(10):997–1002.
   PubMed Web of Science ®Google Scholar
• Stein JH, Currier JS, Hsue PY. Arterial disease in patients with human immunodeficiency virus infection: what has imaging taught us? JACC Cardiovasc Imaging. 2014;7(5):515–525.
   PubMed Web of Science ®Google Scholar
• van Wijk JP, de Koning EJ, Cabezas MC, Joven J, op't Roodt J, Rabelink TJet al., Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients. J Am Coll Cardiol. 2006;47(6):1117–1123.
   PubMed Web of Science ®Google Scholar
• Solages A, Vita JA, Thornton DJ, Murray J, Heeren T, Craven DEet al., Endothelial function in HIV-infected persons. Clin Infect Dis. 2006;42(9):1325–1332.
   PubMed Web of Science ®Google Scholar
• Neuhaus J, Jacobs DR Jr, Baker JV, Calmy A, Duprez D, La Rosa Aet al., Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis. 2010;201(12):1788–1795.
   PubMed Web of Science ®Google Scholar
• Triant VA, Meigs JB, Grinspoon SK. Association of C-reactive protein and HIV infection with acute myocardial infarction. J Acquir Immune Defic Syndr. 2009;51(3):268–273.
   PubMed Web of Science ®Google Scholar
• Duprez DA, Neuhaus J, Kuller LH, Tracy R, Belloso W, De Wit Set al., Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PloS One. 2012;7(9):e44454.
   PubMed Web of Science ®Google Scholar
• Nordell AD, McKenna M, Borges ÁH, Duprez D, Neuhaus J, Neaton JDet al., Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation. J Am Heart Assoc. 2014;3(3):e000844.
   PubMed Web of Science ®Google Scholar
• Fisher SD, Miller TL, Lipshultz SE. Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis. Atherosclerosis. 2006;185(1):1–11.
   PubMed Web of Science ®Google Scholar
• Maniar A, Ellis C, Asmuth D, Pollard R, Rutledge J. HIV infection and atherosclerosis: evaluating the drivers of inflammation. Eur J Prev Cardiol. 2013;20(5):720–728.
   PubMed Web of Science ®Google Scholar
• Nolan D, Watts GF, Herrmann SE, French MA, John M, Mallal S. Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk? QJM. 2003;96(11):825–832.
   PubMed Web of Science ®Google Scholar
• Torriani FJ, Komarow L, Parker RA, Cotter BR, Currier JS, Dubé MPet al., Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: the ACTG (AIDS Clinical Trials Group) Study 5152s. J Am Coll Cardiol. 2008;52(7):569–576.
   PubMed Web of Science ®Google Scholar
• Ho JE, Scherzer R, Hecht FM, Maka K, Selby V, Martin JNet al., The association of CD4+T-cell counts and cardiovascular risk in treated HIV disease. AIDS. 2012;26(9):1115–1120.
   PubMed Web of Science ®Google Scholar
• Charakida M, Donald AE, Green H, Storry C, Clapson M, Caslake Met al., Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy. Circulation. 2005;112(1):103–109.
   PubMed Web of Science ®Google Scholar
• Stein JH, Brown TT, Ribaudo HJ, Chen Y, Yan M, Lauer-Brodell Eet al., Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection. AIDS. 2013;27(6):929–937.
   PubMed Web of Science ®Google Scholar
• Dube MP, Shen C, Mather KJ, Waltz J, Greenwald M, Gupta SK. Relationship of body composition, metabolic status, antiretroviral use, and HIV disease factors to endothelial dysfunction in HIV-infected subjects. AIDS Res Hum Retroviruses. 2010;26(8):847–854.
   PubMed Web of Science ®Google Scholar
• Shikuma CM, Seto T, Liang CY, Bennett K, DeGruttola V, Gerschenson Met al., Vitamin D levels and markers of arterial dysfunction in HIV. AIDS Res Hum Retroviruses. 2012;28(8):793–797.
   PubMed Web of Science ®Google Scholar
• National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–3121.
   PubMed Web of Science ®Google Scholar
• Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MAet al., Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39(2):257–265.
   PubMed Web of Science ®Google Scholar
• Shikuma CM, Barbour JD, Ndhlovu LC, Keating SM, Norris PJ, Budoff Met al., Plasma monocyte chemoattractant protein-1 and tumor necrosis factor-alpha levels predict the presence of coronary artery calcium in HIV-infected individuals independent of traditional cardiovascular risk factors. AIDS Res Hum Retroviruses. 2014;30(2):142–146.
   PubMed Web of Science ®Google Scholar
• Moens AL, Goovaerts I, Claeys MJ, Vrints CJ. Flow-mediated vasodilation: a diagnostic instrument, or an experimental tool? Chest. 2005;127(6):2254–2263.
   PubMed Web of Science ®Google Scholar
• Du Clos TW. Pentraxins: structure, function, and role in inflammation. ISRN Inflamm. 2013;2013:379040.
   PubMedGoogle Scholar
• Bassi N, Zampieri S, Ghirardello A, Tonon M, Zen M, Cozzi Fet al., Pentraxins, anti-pentraxin antibodies, and atherosclerosis. Clin Rev Allergy Immunol. 2009;37(1):36–43.
   PubMed Web of Science ®Google Scholar
• Jenny NS, Arnold AM, Kuller LH, Tracy RP, Psaty BM. Serum amyloid P and cardiovascular disease in older men and women: results from the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 2007;27(2):352–358.
   PubMed Web of Science ®Google Scholar
• Gleason RL Jr, Caulk AW, Seifu D, Parker I, Vidakovic B, Getenet Het al., Current Efavirenz (EFV) or ritonavir-boosted lopinavir (LPV/r) use correlates with elevate markers of atherosclerosis in HIV-infected subjects in Addis Ababa. Ethiopia. PloS One. 2015;10(4):e0117125.
   PubMed Web of Science ®Google Scholar
• Wohl DA, Arnoczy G, Fichtenbaum CJ, Campbell T, Taiwo B, Hicks Cet al., Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study. Antivir Ther. 2014;19(2):141–147.
   PubMed Web of Science ®Google Scholar
• Yasunaga T, Ikeda S, Koga S, Nakata T, Yoshida T, Masuda Net al., Plasma pentraxin 3 is a more potent predictor of endothelial dysfunction than high-sensitive C-reactive protein. Int Heart J. 2014;55(2):160–164.
   PubMed Web of Science ®Google Scholar
• Vita JA, Keaney JF Jr, Larson MG, Keyes MJ, Massaro JM, Lipinska Iet al., Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation. 2004;110(23):3604–3609.
   PubMed Web of Science ®Google Scholar
• Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation. 2001;103(9):1194–1197.
   PubMed Web of Science ®Google Scholar
• Singh U, Dasu MR, Yancey PG, Afify A, Devaraj S, Jialal I. Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats. J Lipid Res. 2008;49(5):1015–1023.
   PubMed Web of Science ®Google Scholar
• Stewart CR, Tseng AA, Mok YF, Staples MK, Schiesser CH, Lawrence LJet al., Oxidation of low-density lipoproteins induces amyloid-like structures that are recognized by macrophages. Biochemistry. 2005;44(25):9108–9116.
   PubMed Web of Science ®Google Scholar
• de Haas CJ, Poppelier MJ, van Kessel KP, van Strijp JA. Serum amyloid P component prevents high-density lipoprotein-mediated neutralization of lipopolysaccharide. Infect Immun. 2000;68(9):4954–4960.
   PubMed Web of Science ®Google Scholar
• Blodget E, Shen C, Aldrovandi G, Rollie A, Gupta SK, Stein JHet al., Relationship between microbial translocation and endothelial function in HIV infected patients. PloS One. 2012;7(8):e42624.
   PubMed Web of Science ®Google Scholar
• Stewart CR, Haw A 3rd, Lopez R, McDonald TO, Callaghan JM, McConville MJet al., Serum amyloid P colocalizes with apolipoproteins in human atheroma: functional implications. J Lipid Res. 2007;48(10):2162–2171.
   PubMed Web of Science ®Google Scholar
• Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today. 1994;15(2):81–88.
   PubMedGoogle Scholar
• Song Z, Cai L, Guo L, Tsukamoto Y, Yutani C, Li XA. Accumulation and expression of serum amyloid P component in human atherosclerotic lesions. Atherosclerosis. 2010;211(1):90–95.
   PubMed Web of Science ®Google Scholar
• Bisoendial RJ, Kastelein JJ, Stroes ES. C-reactive protein and atherogenesis: from fatty streak to clinical event. Atherosclerosis. 2007;195(2):e10–e18.
   PubMed Web of Science ®Google Scholar